# Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Esophagus

> **NCT00030862** · PHASE2 · COMPLETED · sponsor: **Memorial Sloan Kettering Cancer Center**

## Conditions studied

- Esophageal Cancer

## Interventions

- **DRUG:** cisplatin
- **DRUG:** irinotecan hydrochloride

## Key facts

- **NCT ID:** NCT00030862
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-10
- **Primary completion:** 2003-12
- **Final completion:** 2003-12
- **Target enrollment:** — (—)
- **Last updated:** 2013-06-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00030862

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00030862, "Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Esophagus". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00030862. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*